Show simple item record

Certain 8-amino-9-(benzyl)guanines as potential purine nucleoside phosphorylase inhibitors

dc.contributor.authorChem, J. W.en_US
dc.contributor.authorWise, Dean S.en_US
dc.contributor.authorShewach, Donna S.en_US
dc.contributor.authorDaddona, Peter E.en_US
dc.contributor.authorTownsend, Leroy B.en_US
dc.date.accessioned2006-04-10T18:24:27Z
dc.date.available2006-04-10T18:24:27Z
dc.date.issued1994en_US
dc.identifier.citationChem, JW, Wise, DS, Shewach, DS, Daddona, PE, Townsend, LB (1994)."Certain 8-amino-9-(benzyl)guanines as potential purine nucleoside phosphorylase inhibitors." European Journal of Medicinal Chemistry 29(1): 3-9. <http://hdl.handle.net/2027.42/31845>en_US
dc.identifier.urihttp://www.sciencedirect.com/science/article/B6VKY-4C9YYM5-VX/2/188d6087ddccc785df99f577a3a60f99en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/31845
dc.description.abstractSeveral 8-amino-9-(benzyl)guanines were selected for synthesis as potential purine nucleoside phosphorylase (PNP) inhibitors on the basis of the Topliss decision tree. These compounds were prepared by the treatment of oxazolo[5,4-d]pyrimidine intermediates with potassium carbonate in a 1-pot reaction. All compounds were evaluated for PNP inhibitory activity using an in vitro enzyme inhibition assay. The extent of binding to PNP appeared to be influenced by the presence of electron donating substituents on the phenyl ring of the benzyl group. None of the tested compounds were more active than the parent compound, 8-amino-9-benzylguanine. The inhibitory activity seems to be most likely -[sigma]-dependent.en_US
dc.format.extent866870 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherElsevieren_US
dc.titleCertain 8-amino-9-(benzyl)guanines as potential purine nucleoside phosphorylase inhibitorsen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelChemistryen_US
dc.subject.hlbsecondlevelChemical Engineeringen_US
dc.subject.hlbsecondlevelBiological Chemistryen_US
dc.subject.hlbtoplevelEngineeringen_US
dc.subject.hlbtoplevelScienceen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Biological Chemistry, University of Michigan, Ann Arbor, MI, USA; Department of Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor, MI, USA.en_US
dc.contributor.affiliationumDepartment of Biological Chemistry, University of Michigan, Ann Arbor, MI, USA; Department of Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor, MI, USA.en_US
dc.contributor.affiliationumDepartment of Chemistry, University of Michigan, Ann Arbor, MI, USAen_US
dc.contributor.affiliationumDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI, USAen_US
dc.contributor.affiliationumDepartment of Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor, MI, USAen_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/31845/1/0000793.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1016/0223-5234(94)90119-8en_US
dc.identifier.sourceEuropean Journal of Medicinal Chemistryen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.